These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 31545454)
21. The oncogenic role of NKAP in the growth and invasion of colon cancer cells. Shu W; Liu G; Dai Y; Feng A; Chen Z; Han J; Li X Oncol Rep; 2019 Nov; 42(5):2130-2138. PubMed ID: 31545474 [TBL] [Abstract][Full Text] [Related]
22. Upregulation of GNL3 expression promotes colon cancer cell proliferation, migration, invasion and epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway. Tang X; Zha L; Li H; Liao G; Huang Z; Peng X; Wang Z Oncol Rep; 2017 Oct; 38(4):2023-2032. PubMed ID: 28849076 [TBL] [Abstract][Full Text] [Related]
23. TFF3 and TFF1 expression levels are elevated in colorectal cancer and promote the malignant behavior of colon cancer by activating the EMT process. Yusufu A; Shayimu P; Tuerdi R; Fang C; Wang F; Wang H Int J Oncol; 2019 Oct; 55(4):789-804. PubMed ID: 31432157 [TBL] [Abstract][Full Text] [Related]
24. Transcriptional repression of miR-200 family members by Nanog in colon cancer cells induces epithelial-mesenchymal transition (EMT). Pan Q; Meng L; Ye J; Wei X; Shang Y; Tian Y; He Y; Peng Z; Chen L; Chen W; Bian X; Wang R Cancer Lett; 2017 Apr; 392():26-38. PubMed ID: 28163188 [TBL] [Abstract][Full Text] [Related]
25. Suppression of B3GNT7 gene expression in colon adenocarcinoma and its potential effect in the metastasis of colon cancer cells. Lu CH; Wu WY; Lai YJ; Yang CM; Yu LC Glycobiology; 2014 Apr; 24(4):359-67. PubMed ID: 24418929 [TBL] [Abstract][Full Text] [Related]
26. Glucose-regulated protein 78 (GRP78) regulates colon cancer metastasis through EMT biomarkers and the NRF-2/HO-1 pathway. Chang YJ; Chen WY; Huang CY; Liu HH; Wei PL Tumour Biol; 2015 Mar; 36(3):1859-69. PubMed ID: 25431258 [TBL] [Abstract][Full Text] [Related]
27. Loss of KAI1 expression in the progression of colorectal cancer. Lombardi DP; Geradts J; Foley JF; Chiao C; Lamb PW; Barrett JC Cancer Res; 1999 Nov; 59(22):5724-31. PubMed ID: 10582691 [TBL] [Abstract][Full Text] [Related]
28. L1-mediated colon cancer cell metastasis does not require changes in EMT and cancer stem cell markers. Gavert N; Vivanti A; Hazin J; Brabletz T; Ben-Ze'ev A Mol Cancer Res; 2011 Jan; 9(1):14-24. PubMed ID: 21123622 [TBL] [Abstract][Full Text] [Related]
29. FERMT1 mediates epithelial-mesenchymal transition to promote colon cancer metastasis via modulation of β-catenin transcriptional activity. Liu CC; Cai DL; Sun F; Wu ZH; Yue B; Zhao SL; Wu XS; Zhang M; Zhu XW; Peng ZH; Yan DW Oncogene; 2017 Mar; 36(13):1779-1792. PubMed ID: 27641329 [TBL] [Abstract][Full Text] [Related]
30. Dehydropeptidase 1 promotes metastasis through regulation of E-cadherin expression in colon cancer. Park SY; Lee SJ; Cho HJ; Kim TW; Kim JT; Kim JW; Lee CH; Kim BY; Yeom YI; Lim JS; Lee Y; Lee HG Oncotarget; 2016 Feb; 7(8):9501-12. PubMed ID: 26824987 [TBL] [Abstract][Full Text] [Related]
31. miR-378 suppresses the proliferation, migration and invasion of colon cancer cells by inhibiting SDAD1. Zeng M; Zhu L; Li L; Kang C Cell Mol Biol Lett; 2017; 22():12. PubMed ID: 28725241 [TBL] [Abstract][Full Text] [Related]
32. Loss of periplakin expression is associated with the tumorigenesis of colorectal carcinoma. Li X; Zhang G; Wang Y; Elgehama A; Sun Y; Li L; Gu Y; Guo W; Xu Q Biomed Pharmacother; 2017 Mar; 87():366-374. PubMed ID: 28068625 [TBL] [Abstract][Full Text] [Related]
33. Dexamethasone inhibits hypoxia-induced epithelial-mesenchymal transition in colon cancer. Kim JH; Hwang YJ; Han SH; Lee YE; Kim S; Kim YJ; Cho JH; Kwon KA; Kim JH; Kim SH World J Gastroenterol; 2015 Sep; 21(34):9887-99. PubMed ID: 26379394 [TBL] [Abstract][Full Text] [Related]
34. PAK5-mediated E47 phosphorylation promotes epithelial-mesenchymal transition and metastasis of colon cancer. Zhu G; Li X; Guo B; Ke Q; Dong M; Li F Oncogene; 2016 Apr; 35(15):1943-54. PubMed ID: 26212009 [TBL] [Abstract][Full Text] [Related]
35. IGFBP7 downregulation is associated with tumor progression and clinical outcome in hepatocellular carcinoma. Tomimaru Y; Eguchi H; Wada H; Kobayashi S; Marubashi S; Tanemura M; Umeshita K; Kim T; Wakasa K; Doki Y; Mori M; Nagano H Int J Cancer; 2012 Jan; 130(2):319-27. PubMed ID: 21328580 [TBL] [Abstract][Full Text] [Related]
36. Epigenetic Downregulation and Growth Inhibition of IGFBP7 in Gastric Cancer. Kim J; Kim WH; Byeon SJ; Lee BL; Kim MA Asian Pac J Cancer Prev; 2018 Mar; 19(3):667-675. PubMed ID: 29580038 [TBL] [Abstract][Full Text] [Related]
37. CD44 enhances the epithelial-mesenchymal transition in association with colon cancer invasion. Cho SH; Park YS; Kim HJ; Kim CH; Lim SW; Huh JW; Lee JH; Kim HR Int J Oncol; 2012 Jul; 41(1):211-8. PubMed ID: 22552741 [TBL] [Abstract][Full Text] [Related]
38. HCRP1 downregulation promotes hepatocellular carcinoma cell migration and invasion through the induction of EGFR activation and epithelial-mesenchymal transition. Xu J; Zhang X; Wang H; Ge S; Gao T; Song L; Wang X; Li H; Qin Y; Zhang Z Biomed Pharmacother; 2017 Apr; 88():421-429. PubMed ID: 28122307 [TBL] [Abstract][Full Text] [Related]
39. MiR-3653 inhibits the metastasis and epithelial-mesenchymal transition of colon cancer by targeting Zeb2. Zhu W; Luo X; Fu H; Liu L; Sun P; Wang Z Pathol Res Pract; 2019 Oct; 215(10):152577. PubMed ID: 31405759 [TBL] [Abstract][Full Text] [Related]
40. Colon cancer at the molecular level--usefulness of epithelial-mesenchymal transition analysis. Todosi AM; Gavrilescu MM; Aniţei GM; Filip B; Scripcariu V Rev Med Chir Soc Med Nat Iasi; 2012; 116(4):1106-11. PubMed ID: 23700897 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]